Recurring concern

Inadequate review of long-term medication use

Pin Get email alerts Request correction

First reported 10 Jan 2014•Latest report 30 Jun 2025

Definition

What this concern includes

Includes failures of the end-to-end long-term medication review process, including missing or inadequate formal review arrangements, untimely reviews, reviews based on insufficient clinical knowledge, and failures to reassess continued suitability or medication risks.

Not included

  • Excludes review failures concerning only short-term or acute medication courses unless the report explicitly connects them to long-term medication review.
  • Excludes medication administration, prescribing, supply or reconciliation failures that are not part of reviewing ongoing long-term medication use.
  • Excludes generic staffing, training, documentation or electronic-alert failures unless they are explicitly dedicated to the long-term medication review process.
  • Excludes medication review concerns involving a different named clinical process, such as specialist treatment review, unless long-term medication review is the shared unsafe condition.
Reports
14

Distinct published reports

Individual concerns
17

A report can raise multiple concerns

Date range
2014–2025

First to latest report issue date

Stated actions
72

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

Department of Health and Social Care3
NHS Greater Manchester Integrated Care Board3
National Institute for Health and Care Excellence2
NHS England2
Recipient name withheld2
Bexley Medical Group1
Browning Street Surgery1
Delamere Medical Practice1
Devon Local Medical Committee1
Devon Partnership NHS Trust1
Donneybrook Medical Centre1
Fitzalan Medical Group1
Flixton Road Medical Centre1
Fremington Medical Centre1
General Medical Council1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Exeter and Greater Devon

    AI-generated summary

    Carly Marie GORDON · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Carly Marie GORDON was admitted to hospital after a failed attempt on her own life and was later found hanging at home on 27 May 2016 after being discharged to her mother's care. The inquest concluded that she took her own life while suffering from depressive disorder and benzodiazepine withdrawal; concerns related to the long-term prescribing and review of benzodiazepines.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to review patients receiving extended-term medication for suitability of continued long-term use

    Wider context from the report

    “(2) All patients who receive this drug for an extended period of time should be reviewed by their medical advisors to reassess their suitability for the long term use of this particular medication. ”

    Source location

    Carly Marie GORDON · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Remind practices through the regular electronic newsletter to review patients receiving short-acting benzodiazepines.

    Verbatim wording from the response

    “Devon LMC is dedicated to maintaining high standards of care and professionalism and is very happy to help disseminate important information in an appropriate manner to our members and constituent practices. I can confirm the LMC, via our regular electronic newsletter, will remind practices regarding review of patients receiving short acting Benzodiazepines.”

    Source location

    2017-0320-Response-by-Devon-LMC_Redacted
    Page 1 · response
    Published 3 December 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Make the relevant short-acting benzodiazepine review information available on the Devon LMC website.

    Verbatim wording from the response

    “In addition, we will ensure the information is made available on our website. Please could I ask you to provide a link to the relevant documentation?”

    Source location

    2017-0320-Response-by-Devon-LMC_Redacted
    Page 1 · response
    Published 3 December 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Audit patients prescribed Lorazepam and all practice patients receiving it on repeat prescription.

    Verbatim wording from the response

    “In regard to my own personal prescribing I have audited every patient I have prescribed Lorazepam to between 27/05/2016 and 13/09/2017.”

    Source location

    2017-0320-Response-by-Fremington-Medical-Centre
    Page 3 · response
    Published 3 December 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Send personal letters asking patients with repeat benzodiazepine prescriptions to arrange targeted medication reviews.

    Verbatim wording from the response

    “Reviewing medication is regular practice at our surgery. However we have now considered a structured systemic approach for patients on Benzodiazepines to those reviews following our own significant event discussion of this case and the regulation 28 report.”

    Source location

    2017-0320-Response-by-Fremington-Medical-Centre
    Page 4 · response
    Published 3 December 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Remind prescribing staff to discuss short-term benzodiazepine use, conduct regular reviews, and avoid adding these medicines to repeat prescriptions.

    Verbatim wording from the response

    “For those thought requiring acute prescriptions we have reminded prescribing staff of the requirement to discuss with patients about the short term use of Benzodiazepines and regular reviews of both symptoms and prescriptions; also, not to add these medications to repeat prescriptions. I hope my own personal audit evidences that.”

    Source location

    2017-0320-Response-by-Fremington-Medical-Centre
    Page 4 · response
    Published 3 December 2017

    Open published response
  2. Wiltshire and Swindon

    AI-generated summary

    Tania Salekovna Hristova · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Tania Salekovna Hristova had depression and received Citalopram by repeat prescription for five and a half years. She was found hanging by a ligature at home after becoming distressed, and the inquest concluded that her death was suicide. The concerns identified were inadequate review of her medication and mental health, and failure to offer counselling or CBT.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of adequate review of antidepressant medication

    Wider context from the report

    “(1) This patient was prescribed antidepressant medication for 5 ½ years without adequate review. ”

    Source location

    Tania Salekovna Hristova · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Record written medication-review summaries alongside medication-review codes to support reliable audits and identify patients needing review.

    Verbatim wording from the response

    “At the significant event meeting, awareness was raised about the use of medication review codes. It was agreed that a written summary of the medication review was required to be recorded in the patient’s notes with the medication review “read code”. The use of medication review codes allows reliable audits to be performed and to identify patients that require a medication review.”

    Source location

    2015-0392-Response
    Page 1 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Audit patients taking SSRI antidepressants who were due medication reviews and arrange appointments by telephone or in person.

    Verbatim wording from the response

    “An audit was undertaken to help identify patients on SSRI antidepressants that were due to have a medication review and arrangements were made to contact those patients to make a review appointment either by telephone or to take place in person at the surgery.”

    Source location

    2015-0392-Response
    Page 2 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Notify repeat-prescription patients about medication reviews, count down repeat issues, and contact persistent non-attenders through telephone, letters, electronic messages, and pharmacists.

    Verbatim wording from the response

    “There is currently a system in place whereby patients on repeat medications are notified that they ought to make an appointment for a medication review on their reorder form when they request a prescription. There is a “counting down” procedure each time they request a repeat prescription. Patients that repeatedly ignore this are being contacted by telephone or letter asking them to make a medication review appointment or a message asking them to make an appointment is added to their electronic prescription. As part of our investigations, we have contacted local pharmacists and asked them to ensure that the messages are duly passed on to patients.”

    Source location

    2015-0392-Response
    Page 2 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Send all patients taking SSRI antidepressants invitations to medication reviews with information about antidepressants and stopping treatment.

    Verbatim wording from the response

    “As part of improving our management of patients on SSRI antidepressants, partners agreed that we would write to all such patients to invite them to attend for a medication review and provide additional information about coming off antidepressants and about SSRI antidepressants generally. A copy of the letter is enclosed for information.”

    Source location

    2015-0392-Response
    Page 2 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Advise patients taking SSRI antidepressants to have an annual medication review during their birthday month.

    Verbatim wording from the response

    “As an additional measure, patients are also being advised to have an annual medication review in the month of their birthday.”

    Source location

    2015-0392-Response
    Page 2 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Repeat-audit SSRI antidepressant patients due medication reviews and assess identified patients individually over six months as resources permit.

    Verbatim wording from the response

    “A repeat audit of patients on SSRI antidepressants was performed in October 2015. This consisted of a computer database search of such patients who are due to have a medication review. These patients are being considered on a case by case basis over the next 6 months as resources permit.”

    Source location

    2015-0392-Response
    Page 2 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Upgrade repeat prescribing to electronic prescribing and online ordering, enabling prescription messages and review requirements at the final issue.

    Verbatim wording from the response

    “The practice has reviewed its repeat prescribing system and has now upgraded to electronic prescribing. This allows messages to be added electronically to prescriptions which the patient can read themselves or the pharmacist can then pass on, (if their prescription is sent to the pharmacist). The surgery has also moved over to an online ordering facility through our clinical computer system. Patients register securely to obtain password and log in details, which then allows them to request repeat medications that still have issues remaining. Once the medication has reached its last issue it would then require a medication review.”

    Source location

    2015-0392-Response
    Page 2 · response
    Published 28 September 2015

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Existing surgery systems are considered robust and sufficient to ensure medication reviews and counselling offers for patients taking SSRI antidepressants.

    Verbatim wording from the response

    “The partners have taken substantial additional steps to address the points raised and are confident that there is a robust system in place at the surgery to ensure appropriate medication reviews and the offer of counselling to all patients taking SSRI antidepressants.”

    Source location

    2015-0392-Response
    Page 3 · response
    Published 28 September 2015

    Open published response
  3. Black Country

    AI-generated summary

    Bridget May CAHILL · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Bridget May CAHILL died in hospital from a morphine overdose after being admitted with unresponsiveness and receiving treatment including naloxone. The principal concern was how a patient prescribed and receiving less than the maximum permitted morphine dose could nevertheless suffer an overdose, including whether dosing should account for factors such as body weight, comorbidities, and possible accumulation during long-term therapy.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to account for morphine buildup during long-term therapy

    Wider context from the report

    “The evidence I heard was that Mrs. Cahill was admitted to Walsall Manor Hospital on 10th September 2013. She had a one day history of unresponsiveness, had a background of Parkinson’s disease, dementia and chronic backache. She lived in a residential home. On admission she had pinpoint pupils suggesting morphine overdose which was partially reversed with an antidote. Blood tests showed high calcium levels suggestive of dehydration, or possibly a tumour and there was a suggestion of possible ongoing infection. She had treatment with IV fluids, IV antibiotics and Naloxone, but she deteriorated and died. She was on morphine night and morning and also oral morphine during the day if and when required. The maximum dose of Oramorph was 20 millilitres per day, 5 millilitres at a time, dosages to be 4 to 6 hours apart. The evidence I heard was that at no time prior to her death did she have the maximum permitted dose. My concern relates to how it is that a person who is prescribed morphine and who has less than the amount prescribed for them, can nevertheless suffer an overdose. I write to enquire whether attention needs to be given to the maximum dose that can be recommended and whether it is, or should be, subject to factors such as body weight, any co morbidities and any other factors and whether attention should be directed towards the possible buildup of morphine in the body for those involved in long-term therapy. ”

    Source location

    Bridget May CAHILL · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    The evidence does not support excessive accumulation of morphine metabolites in this case, as would be expected from impaired renal elimination.

    Verbatim wording from the response

    “3. Should attention be directed towards the possible build-up of morphine in the body for those involved in long-term therapy?”

    Source location

    2015-0266-Response-by-MHRA
    Page 2 · response
    Published 11 June 2014

    Open published response
  4. Staffordshire South

    AI-generated summary

    Pauline Meredith · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Pauline Meredith, aged 42, was found dead in her flat on 30 August 2013. Her death was attributed to mixed drug toxicity, including a fatal level of morphine, excessive levels of tramadol and propranolol, and alcohol. Concerns included the amount and review of prescribed medication, the addition of morphine alongside existing medication and alcohol dependence, the response to family concerns, the absence of team meetings, and delays in involving community mental health services.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of a formal medication review process for long-term medication prescribing

    Wider context from the report

    “(1) The amount of medication prescribed to the deceased over many years with no formal medication review process. ”

    Source location

    Pauline Meredith · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Consider and initiate independent medication reviews by asking an uninvolved doctor to review complex patients’ medication when appropriate.

    Verbatim wording from the response

    “3) Miss Meredith had seen 3 other doctors and the nurse practitioner in previous 8 months before her death. Having reflected on this case, I recognise that it can often be useful to have another clinician with a fresh pair of eyes looking at patients with chronic problems. The practice will consider whether there are circumstances where the medication reviews are best carried out by another doctor who is not so involved with the case. This would be actioned by the regular doctor asking for a medication review by a colleague who was not involved in management of the case. This is to be initiated from now.”

    Source location

    2014-0011-Response-by-Browning-Street-Surgery
    Page 9 · response
    Published 10 January 2014

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Existing computerised reviews, weekly prescriptions and consultations were considered sufficient to monitor and control medication access.

    Verbatim wording from the response

    “I would wish to reassure you that there is indeed a formal medication review process used at the practice. The medication review system is computer based. The computer automatically initiates a demand for review of medication for each patient who has repeat medications. This is usually annually but can occur more frequently depending on the monitoring requirements stipulated by the prescribing doctor. The computer also places limits on the number of repeats that can be issued without re-authorisation of the repeat medication by a doctor. The review of repeat medication is usually based on clinical information contained in annual health checks or from consultations at the practice or from a dedicated review of repeat medication with the patient.”

    Source location

    2014-0011-Response-by-Browning-Street-Surgery
    Page 2 · response
    Published 10 January 2014

    Open published response
Back to top

Data last updated 7 September 2026